ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,831Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 223

$533K Total Retail Price of All Prescriptions

Rank: 55 out of 223

643 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,438 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 521 460 1 1
OMEPRAZOLE 501 443 2 3
LEVOTHYROXINE SODIUM 473 417 3 2
LISINOPRIL 357 322 4 4
ZOLPIDEM TARTRATE 307 276 5 8
METFORMIN HCL 273 263 6 7
HYDROCODONE-ACETAMINOPHEN 238 193 S3 7 5
CITALOPRAM HBR 204 177 8 16
AMLODIPINE BESYLATE 193 163 9 6
FUROSEMIDE 189 174 10 9
TRAMADOL HCL 173 144 11 18
SERTRALINE HCL 171 146 12 21
HYDROCHLOROTHIAZIDE 159 144 13 13
POTASSIUM CHLORIDE 155 153 14 12
LOSARTAN-HYDROCHLOROTHIAZIDE 151 130 15 31
METOPROLOL SUCCINATE 149 128 16 20
METOPROLOL TARTRATE 145 125 17 25
WARFARIN SODIUM 139 126 18 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 128 19 29
ATENOLOL 130 108 20 32
PRAVASTATIN SODIUM 125 121 21 15
LOSARTAN POTASSIUM 117 116 22 14
FLUTICASONE PROPIONATE 112 95 23 27
ATORVASTATIN CALCIUM 109 96 24 17
GABAPENTIN 102 70 25 10
TAMSULOSIN HCL 92 91 26 26
FENOFIBRATE 76 69 27 38
DIGOXIN 75 75 28 73
AMITRIPTYLINE HCL 75 51 R 28 61
MELOXICAM 69 61 30 33
SYNTHROID 64 60 31 35
CLOPIDOGREL 62 60 32 56
DONEPEZIL HCL 61 56 33 36
NEXIUM 55 55 34 49
GLIPIZIDE 54 52 35 112
PLAVIX 54 54 35 85
AZITHROMYCIN 50 47 37 44
FLUOXETINE HCL 50 39 37 24
ALLOPURINOL 50 43 37 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.